Higher BMI is linked to an increased risk of heart attacks in European adults: a Mendelian randomisation study by Adams, Benjamin et al.
RESEARCH ARTICLE Open Access
Higher BMI is linked to an increased risk of
heart attacks in European adults: a
Mendelian randomisation study
Benjamin Adams, Lauren Jacocks and Hui Guo*
Abstract
Background: BMI has been implicated as a risk factor for heart disease as a whole in multiple studies. Heart attack
is one of the common complications of this disease. The aim of this study is to explore if elevated level of BMI
causes an increase in the risk of heart attacks.
Methods: We used two Mendelian randomisation (MR) methods: inverse variance weighted estimation and robust
adjusted profile score (RAPS) on the basis of summary data of adulthood BMI from Genetic Investigation of
Anthropometric Traits consortium and heart attack data from the UK Biobank. BMI associated single nucleotide
polymorphisms (SNPs) were used as instrumental variables.
Results: Seventy-two independent SNPs were associated with BMI (P < 5 × 10− 8). Using these SNPs as instruments,
BMI was found to be causally associated with heart attacks in inverse variance weighted MR analysis. The risk of
heart attacks increased by 0.8% per 1-SD (or 4.5 kg/m2) increase in BMI (OR = 1.008 with 95% CI (1.003, 1.012), P =
0.001). RAPS provided concordant results (OR = 1.007 with 95% CI (1.002, 1.012), P = 0.004).
Conclusions: This current study is the first to use MR to investigate causal relationship between BMI and heart
attacks. Our findings suggest that high level of BMI may cause increased risk of heart attacks.
Keywords: BMI, Heart attacks, Causal relationship, Mendelian randomisation
Background
The obesity pandemic
It is no secret that being overweight is increasingly be-
coming the norm, with the latest research briefing in the
houses of parliament claiming that 28.7% of adults in
the UK are obese and a further 35.6% are overweight [1].
Obesity measured as a BMI > 30 kg/m2 has been linked
to a plethora of ailments through observational studies
[2–6]. According to the Office for National Statistics, in
2018, the leading cause of deaths in the UK was
ischaemic heart disease for men, accounting for 13.2% of
deaths [7].
BMI has been implicated as a risk factor for heart dis-
ease as a whole [8]. Many studies, however, only seem to
tackle more generalised terms of the disease. A previous
observational study has identified a link between heart
attacks and BMI [4]. They observed a cohort of 899
obese individuals in adults between 35 and 74. After 10
years of observations, the study concluded that obesity
was not an independent cardiovascular risk factor. This
study is statistically underpowered due to small sample
size. Furthermore, like other observational studies, an
obvious issue is that it may suffer from problems of con-
founding (e.g. smoking, alcohol abuse) [9] and other
sources of bias [10]. Conclusions from these studies have
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limited use as clinical development of treatments re-
quires well-targeted causal factors [11–13]. In our study,
we can put this statement to the test as we employ the
use of Mendelian randomisation (MR) to bypass these
issues, with the aim to better infer causality of obesity




In our investigation, we have applied two-sample MR to
explore if an elevated level of BMI (regarded as expos-
ure) causes increased risk of heart attacks (regarded as
outcome) using BMI associated single nucleotide
polymorphisms (SNPs) as the instruments.
Two-sample MR requires participants from two separ-
ate studies – one for exposure and the other for out-
come, where the individuals do not overlap since
overlapping data sets would lead to our results suffering
from inflated type 1 error rates [14]. However, the two
samples must be representative of the same population.
Thus, we have used summary data of European descen-
dants from two independent studies: Genetic Investiga-
tion of Anthropometric Traits (GIANT) consortium (for
BMI) [15] and the UK Biobank (for heart attacks) [16].
BMI data - GIANT
The genetic instruments were SNPs selected from
GIANT [15]. This study consists of a meta-analysis of a
population from European ancestry containing 322,154
individuals from 114 studies. Summary level data was
extracted (see Summary Data section for more details)
for BMI associated SNPs (P < 5 × 10− 8). These SNPs
were further filtered by clumping carried out using the
MR-Base platform [17] to ensure that the final set of
instruments in MR analysis were independent of one an-
other. Essentially the SNPs in linkage disequilibrium
(LD) (R2 ≥ 0.001) were clumped together with only the
SNP with the lowest p-value being retained.
Heart attack data - UK biobank
The UK Biobank data contains approximately half a mil-
lion individuals aged between 40 and 69 years [18]. The
participants were recruited from across the UK between
2006 and 2010 and asked to provide information via
questionnaires, interviews, anthropometric measures and
samples (e.g. blood, urine and saliva). The summary data
we used for heart attacks was from GWAS results by the
Neale lab who carried out rigorous quality control (QC)
checks [16]. These checks whittled down the individuals
involved to only QC positives (n = 337,199). The filter
which caused the largest reduction in participants was
the restriction to white British genetic ancestry only.
Participants were also removed if they were closely
related to other individuals in the study or had sex
chromosome abnormalities. To learn more about the
QC process please see the Neale Lab website [16].
As of 2018, over 92 million autosomal SNPs (directly
genotyped or imputed) were available for analysis. All
these SNPs were further restricted by minor allele fre-
quency (MAF) > 0.1%, Hardy-Weinberg Equilibrium
(HWE) p-value > 1 × 10− 10 in the QC positive individ-
uals and an imputation score INFO > 0.8 leaving ap-
proximately 13.8 million SNPs for analysis [16].
For the heart attack data obtained from the UK
Biobank, participants were asked in a survey on their
medical history to categorically state if they had had a
doctor diagnosed heart attack or stroke, or suffered from
angina or high blood pressure [19]. Participants could
also state if they had suffered from none of the above.
The data from this survey was converted into binary (1:
suffered from a doctor diagnosed heart attack, 0
otherwise).
Summary data
Instead of using individual-level data, one of the advan-
tages of MR analysis is leverage summary statistics at the
SNP level (estimated SNP effects, standard errors and
corresponding p-values from regression models, effect
alleles and other alleles along with their frequencies).
These summary statistics from many large-scale genome
wide association studies (GWAS) are now made publicly
available.
Summary data of BMI and heart attacks were ex-
tracted separately, for BMI associated SNPs, from the
GIANT and UK Biobank studies [15, 16]. In GIANT,
data were standardised such that per unit change in BMI
corresponds to 1 standard deviation (or 4.5 kg/m2)
change in BMI. We then carried out harmonisation
using the TwoSample MR package in R to make sure
that the effects of a SNP on the outcome and exposure
were relative to the same allele, which produced one
merged dataset for our MR analysis.
Statistical analysis
Before the advent of MR, observational studies were
greatly limited by problems of unobserved confounding.
These limitations rendered many findings lack of causal
interpretations. MR, however, circumvents these difficul-
ties by mimicking randomised controlled experiment
and assuming that the instruments (SNPs) fulfil three
criteria listed in Fig. 1.
We used two MR methods: inverse variance weighted
(IVW) estimation and MR robust adjusted profile score
(RAPS) to estimate causal effect of BMI on heart attacks
(log odds ratio), its standard error and corresponding p-
value [20, 21]. Both of the methods require that instru-
mental SNPs are associated with the exposure and
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mutually independent. In IVW estimation, causal effect
of an exposure on an outcome is first estimated as the
ratio of the SNP-outcome association estimate to the
SNP-exposure association estimate for each instrumental
SNP. The IVW estimate is weighted average of these es-
timated causal effects, where each of the estimates is
weighted by the inverse of their variance [22]. An obvi-
ous advantage of IVW is its use of multiple instruments
to improve statistical power. However, it is prone to bias
due to weak instruments. RAPS enhances the IVW esti-
mation by replacing each weight with a function form of
the causal effect and the variation of the instrument
strength [23]. This approach provides more robust re-
sults in the presence of weak instruments than IVW
estimate.
Results
Higher BMI causes increased risk of heart attacks in
European descendants
Seventy-three independent SNPs that are at least 10,000
kb apart were found associated with BMI (Table 1). In
our MR analysis we identified an outlier. The estimated
causal effect of BMI on heart attacks obtained based on
this SNP was more than 3 standard deviations away
from the average causal effect calculated from all the 73
SNPs. We researched that particular outlier rs2075650
(located at bottom left, left panel of Fig. 2) in order to
determine if it exhibits pleiotropy – it also influences
other health conditions apart from heart attacks. Ac-
cording to the Ensembl database, this SNP is located in
the TOMM40 gene and in close proximity to the APOE
gene but may also influence Alzheimer’s disease and
age-related macular degeneration [24].
Both TOMM40 and APOE are located at 19q13.32 in
the genome in chromosome 19 [25]. The protein
encoded by TOMM40 is a channel-forming subunit of
the translocase of the mitochondrial outer membrane. It
is essential for the import of protein precursors into the
mitochondria. The protein APOE, coding for apolipo-
protein E, binds to fats in the blood to form lipoproteins.
This allows for the transport of fats throughout the
bloodstream, preventing the build-up of fats in the blood
that could otherwise contribute to heart disease pheno-
types if left there. Both of the genes have been linked to
white matter integrity in the brain and the onset of
Alzheimer’s disease, although nothing has been conclu-
sively proven [26].
We re-ran MR by excluding the outlier rs2075650 as a
sensitivity analysis. Although this SNP might introduce
pleiotropy, our MR results are concordant, with or with-
out rs2075650, as shown in the two panels of Fig. 2. The
slopes of the lines represent estimated log odds ratios.
Both of the MR methods (IVW in red, RAPS in blue)
have shown evidence for a positive causal effect of BMI
on heart attacks. For simplicity, we only report estimated
causal effect (odds ratio) from MR using the remaining
72 instruments in Table 2.
Table 2 lists results from the two MR methods: inverse
variance weighted (IVW) estimation and robust adjusted
profile score (RAPS) using the 72 independent BMI-
associated SNPs as instruments. Estimated OR:
estimated odds ratio. It states the estimated change in
the risk of having a heart attack, for every 4.5 kg increase
of weight per square metre. 95% CI: 95% confidence
interval.
The risk of heart attacks increased by 0.8% (in IVW)
and 0.7% (in RAPS) per 1-SD (or 4.5 kg/m2) increase in
BMI. The 95% CIs from both of the methods do not in-
clude value 1 implying that the estimated positive causal
effect of BMI on the risk of heart attacks is unlikely to
have occurred due to chance alone.
Discussion
Surrounding research
Our two-sample MR analyses showed evidence for a
positive causal effect of BMI on the risk of heart attacks.
Fig. 1 Schematic representation of assumptions of our MR analysis. In this investigation, MR has been used to test the causal relationship
between BMI and heart attacks in adulthood. The numbers indicate the three assumptions: 1) instrumental SNPs are associated with BMI; 2)
instrumental SNPs are not associated with confounders; 3) instrumental SNPs do not have direct effects on the risk of heart attacks, i.e., their
effects on heart attacks are mediated only through BMI
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Table 1 Summary results of BMI associated independent instrumental SNPs
SNP Chr Position EA OA EAF Beta SE P Gene
rs1343424 1 49,376,820 C T 0.251 0.02 0.004 8.56E-09 AGBL4
rs2422134 1 72,514,701 C G 0.508 −0.022 0.003 2.49E-13 NEGR1
rs6690871 1 74,977,277 G A 0.407 0.022 0.003 1.28E-12 LRRC53
rs505066 1 96,882,671 A C 0.285 0.025 0.004 2.35E-09 (UBE2WP1)
rs7550711 1 110,082,886 T C 0.026 0.066 0.009 9.51E-14 GPR61
rs4478775 1 177,770,097 A G 0.223 0.025 0.004 1.98E-11 SEC16B
rs2820292 1 201,784,287 A C 0.432 −0.02 0.003 1.58E-10 NAV1
rs13411762 2 554,109 C T 0.928 0.033 0.006 5.93E-09 (TMEM18)
rs13391869 2 606,213 G A 0.848 −0.022 0.004 1.65E-08 (TMEM18)
rs10495749 2 24,730,847 A G 0.231 −0.021 0.004 3.21E-09 NCOA1
rs11126666 2 26,928,811 G A 0.745 −0.021 0.003 5.71E-10 KCNK3
rs13011109 2 58,857,419 G C 0.612 0.018 0.003 6.84E-09 FANCL
rs6545714 2 59,307,725 G A 0.399 0.018 0.003 3.19E-09 (FANCL)
rs2890652 2 142,959,931 T C 0.839 −0.028 0.005 2.24E-08 (LRP1B)
rs1528435 2 181,550,962 T C 0.62 0.018 0.003 4.68E-09 (UBE2E3)
rs7599312 2 213,413,231 G A 0.732 0.022 0.003 4.88E-11 (ERBB4)
rs10510554 3 25,099,776 T C 0.431 −0.018 0.003 1.78E-09 RARB
rs1916801 3 61,187,046 A T 0.595 0.019 0.003 8.13E-10 FHIT
rs3849570 3 81,792,112 A C 0.348 0.019 0.003 1.61E-08 GBE1
rs10511073 3 85,653,460 G A 0.646 −0.021 0.003 1.46E-10 CADM2
rs16851483 3 141,275,436 G T 0.934 −0.048 0.008 1.77E-10 RASA2
rs4494964 3 185,776,491 T C 0.142 −0.04 0.005 1.39E-15 ETV5
rs13144044 4 45,082,236 C G 0.534 −0.025 0.004 1.02E-11 (GNPDA2)
rs17001654 4 77,129,568 C G 0.852 −0.031 0.005 3.88E-09 SCARB2
rs13107325 4 103,188,709 C T 0.925 −0.048 0.007 1.15E-12 SLC39A8
rs11727676 4 145,659,064 C T 0.096 −0.036 0.006 1.11E-08 HHIP
rs6871667 5 74,604,742 A G 0.401 −0.017 0.003 1.44E-08 (HMGCR)
rs280275 6 50,668,612 A G 0.952 −0.039 0.007 4.46E-09 (TFAP2D)
rs4141973 6 50,946,521 T C 0.134 0.028 0.005 5.51E-09 (FTH1P5)
rs9400239 6 108,977,663 C T 0.706 0.019 0.003 6.10E-09 FOXO3
rs13191362 6 163,033,350 A G 0.875 0.028 0.005 3.94E-09 PARK2
rs1167827 7 75,163,169 A G 0.435 −0.02 0.003 4.64E-10 HIP1
rs2245368 7 76,608,143 T C 0.833 −0.032 0.006 1.34E-08 DTX2P1
rs2922763 8 76,573,711 G T 0.274 −0.024 0.004 2.73E-10 (HNF4G)
rs2033732 8 85,079,709 C T 0.744 0.019 0.004 2.06E-08 (RALYL)
rs4740619 9 15,634,326 T C 0.551 0.018 0.003 3.87E-09 CCDC171
rs1412234 9 28,410,683 C T 0.33 0.024 0.004 4.97E-09 LINGO2
rs6477694 9 111,932,342 C T 0.354 0.017 0.003 9.95E-09 (FRRS1L)
rs1928295 9 120,378,483 C T 0.43 −0.019 0.003 6.62E-10 (TLR4)
rs10733682 9 129,460,914 A G 0.473 0.017 0.003 9.95E-09 LMX1B
rs7899106 10 87,410,904 A G 0.95 −0.04 0.007 1.32E-08 GRID1
rs17094222 10 102,395,440 C T 0.213 0.025 0.004 2.83E-11 (PAX2)
rs17747324 10 114,752,503 C T 0.227 −0.023 0.004 1.16E-09 TCF7L2
rs1374262 11 8,458,749 G A 0.532 0.017 0.003 1.44E-08 STK33
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There are many previous studies that have used MR and
reported a causal link between BMI and cardiovascular
diseases [3, 27, 28]. To the best of our knowledge, how-
ever, this current study is the first to use MR to explore
if increased BMI causes an increase specifically in the
risk of heart attacks. This is important as the root causes
of cardiovascular diseases as a whole are generally too
broad to find the biological reasoning behind the mecha-
nisms. Choosing a smaller target makes interpretation of
these mechanisms much clearer.
This new evidence aids the growing theory that obes-
ity is associated with a heightened risk of a plethora of
cardiac related disease phenotypes. Such studies that
have also contributed to this theory include one which
linked BMI to heart failure using the ENGAGE consor-
tium (n = 19,384) [29], and another which used the UK
Biobank to link BMI to aortic valve stenosis (n = 367,
703) [27]. The latter study also related BMI to a lot of
other cardiovascular diseases and so came the closest to
detailing the causal effect of BMI on heart attacks
although they did not explicitly state this. Furthermore,
the BMI data they used was sourced elsewhere to
GIANT. Overall, it seems that much of existing
research does support similar evidence that BMI is
related to a large array of heart disease, including heart
attacks.
Table 1 Summary results of BMI associated independent instrumental SNPs (Continued)
SNP Chr Position EA OA EAF Beta SE P Gene
rs4514364 11 27,456,059 C T 0.316 0.02 0.003 1.72E-09 LGR4
rs2176598 11 43,864,278 T C 0.246 0.02 0.004 1.90E-08 HSD17B12
rs2856650 11 47,365,199 G A 0.703 −0.02 0.003 9.87E-10 MYBPC3
rs12286929 11 115,022,404 G A 0.527 0.022 0.003 1.28E-12 (CADM1)
rs2720296 12 50,169,070 G A 0.613 −0.02 0.003 9.87E-10 (LSM6P2)
rs11057405 12 122,781,897 A G 0.106 −0.031 0.006 1.19E-08 CLIP1
rs7988412 13 28,000,282 C T 0.815 −0.026 0.005 1.10E-08 GTF3A
rs2797084 13 54,071,824 T C 0.86 − 0.032 0.006 6.12E-09 (OLFM4)
rs10132280 14 25,928,179 A C 0.3 −0.023 0.003 6.68E-12 (STXBP6)
rs2370982 14 79,890,677 T C 0.216 0.025 0.005 2.43E-08 NRXN3
rs3736485 15 51,748,610 A G 0.461 0.018 0.003 6.84E-09 DMXL2
rs12905371 15 67,845,930 C T 0.736 0.021 0.004 4.46E-09 MAP 2 K5
rs12448257 16 3,599,655 G A 0.784 −0.024 0.004 8.42E-10 NLRC3
rs2531995 16 4,013,467 C T 0.379 −0.024 0.004 8.46E-10 ADCY9
rs2354584 16 19,778,575 A G 0.87 0.035 0.006 1.10E-09 IQCK
rs2650492 16 28,333,411 A G 0.298 0.021 0.004 1.67E-09 SBK1
rs2303222 16 31,085,470 C T 0.378 −0.018 0.003 1.78E-09 ZNF668
rs1477199 16 53,712,135 A G 0.864 −0.024 0.004 1.90E-08 RPGRIP1L
rs7205986 16 53,755,146 G A 0.511 0.025 0.003 3.68E-16 FTO
rs3026101 17 5,280,440 C T 0.301 0.018 0.003 1.23E-08 NUP88
rs12949279 17 78,558,411 C T 0.439 −0.018 0.003 8.25E-09 RPTOR
rs891389 18 21,087,531 C T 0.655 −0.021 0.004 2.20E-08 RMC1
rs7243357 18 56,883,319 G T 0.176 −0.022 0.004 2.90E-08 (GRP)
rs4940929 18 57,803,890 G C 0.583 0.027 0.004 3.43E-11 (MC4R)
rs9944545 18 57,958,244 T C 0.297 0.034 0.003 5.66E-24 (MC4R)
rs17724992 19 18,454,825 A G 0.733 0.019 0.004 1.49E-08 PGPEP1
rs29944 19 34,306,898 A G 0.327 −0.018 0.003 2.07E-08 (KCTD15)
rs2075650 19 45,395,619 A G 0.854 0.026 0.005 4.92E-09 TOMM40
rs9304665 19 47,602,577 A T 0.765 0.025 0.004 7.61E-09 ZC3H4
Table 1 lists summary results of the 73 independent SNPs used as instruments in our MR analysis. These SNPs were associated with BMI (P < 5 × 10−8) in the
European adults in the GIANT study. One SNP rs2075650 appeared to be an outlier. We re-did MR analysis without this SNP. SNP: single nucleotide polymorphism,
Chr: chromosome, Position: location of the SNP in the chromosome according to Build 37, EA: effect allele, OA: the other allele, EAF: effect allele frequency. Beta,
SE and P are estimated SNP effect, standard error and p-value from the GIANT GWAS study. Gene: genes of the SNPs located in or close to. For intergenic SNPs,
their nearest genes are provided in brackets
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Biological mechanism
High BMI values have been found to cause hypertension
through MR tests [30, 31]. These results were reported
to be independent of age, sex or confounders such as
smoking and alcohol intake. Hypertension adds force
onto the arterial walls as blood flows through. Contin-
ued exposure to these larger forces increases the chances
of arterial wall damage and the accumulation of choles-
terol, other lipids and therefore plaques. Plaques can
narrow the diameter of the arteries that provide oxygen-
ated blood to the heart muscle. This is usually asymp-
tomatic but cases of angina or other chest pains are
common, especially when one is exerting themselves.
Eventually, the plaque will either grow to fully occlude
the lumen of the artery or potentially break off to block
a narrower section downstream of the plaque. In both
instances, blood flow is cut off to the heart and so the
individual experiences a heart attack (myocardial infarc-
tion) which can be fatal.
Elevated BMI has also been associated with increased
blood interleukin 6 (IL-6) and expression of its receptor
IL-6R [6]. IL-6 has been linked to the development of
atherosclerotic plaques through increasing the rate of
synthesis of its components. Lipid concentrations, blood
glucose, C-reactive protein (CRP), interleukin 18 and
adiponectin are also commonly used as markers for
heart attacks and have been shown to be increased in
the obese [32].
Though this is not an exhaustive list of the potential
biological mechanisms behind the causal association be-
tween obesity and heart attacks, they are some of the
most common causes in the UK population. It is import-
ant to note that just because this association is found
through genetic instruments, it does not mean that life-
style changes cannot alter the chances of a heart attack
outcome. Regular exercise and a low-fat diet, along with
weight loss have been shown to reduce the chances of
heart attacks [32].
Strengths & Limitations
Using UK Biobank and GIANT was advantageous for
our investigation due to their large sample size and high
quality of data. Focusing only on European ancestry and
imputed SNPs with high accuracy mitigated primary
confounding factors e.g. population structure and imput-
ation errors.
MR is the star attraction of this investigation. It has
allowed us to investigate the causal association of BMI
on heart attacks without the usual pitfalls of con-
founders being an issue. The MR design has many
strengths as it relies solely on genetic instruments.
Fig. 2 MR results with (left panel) and without (right panel) outlier SNP rs2075650. Each dot, corresponding to one of the instrumental SNPs of
the investigation, represents estimated regression coefficient of the SNP on BMI (horizontal axis) and on heart attacks (vertical axis). The slopes are
causal effects (log odds ratios) of BMI on heart attacks estimated from two MR methods: inverse variance weighted (IVW) estimation (red) and
robust adjusted profile score (RAPS) (blue)
Table 2 Estimated causal effect of BMI on heart attacks from
two MR methods
MR Method Estimated OR 95% CI P-value
IVW 1.008 (1.003, 1.012) 0.001
RAPS 1.007 (1.002, 1.012) 0.004
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Alleles are randomly sorted and become fixed at concep-
tion and MR then directly tests these alleles, which by-
passes biases due to confounding and reverse causality.
A limitation very common to MR studies is pleiotropy,
and this study is no exception. Pleiotropy was the reason
for the removal of SNP rs2075650 due to the belief that
the SNP was also associated with Alzheimer’s disease.
The use of a robust method RAPS means that our ana-
lysis was improved by reducing the likelihood of biased
results due to weak instruments.
A limitation of our study was the terminology used in
the UK Biobank data with reference to the outcome.
The term ‘heart attack’ can be open to interpretation
when it comes to what actually went wrong in the body.
Not only because there are five recognised forms of
heart attacks [33], but also because to a member of the
public answering the UK Biobank questionnaires, they
may believe their coronary thrombosis to be a heart at-
tack, when in fact in this investigation we assumed by
heart attack, the participant was referring to a myocar-
dial infarction, which while similar in its outcome, has
different causes.
Conclusions
Upon conducting MR analysis on European descendants,
this investigation has shown some evidence that a higher
BMI causes an increased risk of an individual having a
heart attack. Therefore, individuals who are overweight
should look to reduce their weight and health services
should look to producing guidelines that encourage this
behaviour.
These findings suggest that parameters should be put
in place following consultations with obese and over-
weight patients that look to induce their weight loss as
we now know that it may have a direct causal associ-
ation with heart attacks. Such parameters could be an
automatic appointment with a dietitian or a leaflet on
local places to exercise. Should future GWAS re-impute
the same data, their questionnaires on heart attacks
should contain more specific terminology (i.e. instead of
asking whether the patient has had a heart attack, they
could ask which type of myocardial infarction they have
had). Then MR analysis could be carried out on BMI’s
causal association with each type of myocardial infarc-
tion. This could help with reducing wasting the afore-
mentioned parameters on patients who potentially
would not benefit from them. Future research could also
focus on the action of the proteins the identified SNPs
are related to and on understanding their function in the
body.
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